Invus Global Management, LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Kalaris Therapeutics, Inc. Common Stock, $0.0001 par value per share (KLRS)

Filing Manager
Invus Global Management, LLC
Reporting Manager
Invus Public Equities, L.P.
Security
Kalaris Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
KLRS
Shares outstanding
18,839,067 shares
Disclosed Ownership
282,586 shares
Ownership
1.5%
Form type
SCHEDULE 13G/A
Filing time
29 Jul 2025, 13:21:24 UTC
Date of event
30 Jun 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Invus Public Equities, L.P. 1.5% 282,586 282,586 0 /s/ Raymond Debbane Raymond Debbane, President of Invus Public Equities Advisors, LLC, its general partner
Invus Public Equities Advisors, LLC 1.5% 282,586 282,586 0 /s/ Raymond Debbane Raymond Debbane, President
Invus Global Management, LLC 1.5% 282,586 282,586 0 /s/ Raymond Debbane Raymond Debbane, President
Siren, L.L.C. 1.5% 282,586 282,586 0 /s/ Raymond Debbane Raymond Debbane, President
Raymond Debbane 1.5% 282,586 282,586 0 /s/ Raymond Debbane Raymond Debbane